Human Umbilical Cord Mesenchymal Stem Cell-Based in vitro Model for Neurotoxicity Testing.
cytotoxicity test
mesenchymal stem cells
neuron-like cells
neuronal markers
Journal
Current protocols
ISSN: 2691-1299
Titre abrégé: Curr Protoc
Pays: United States
ID NLM: 101773894
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
entrez:
26
4
2022
pubmed:
27
4
2022
medline:
29
4
2022
Statut:
ppublish
Résumé
Neurotoxicity (NT) testing for regulatory purposes is based on in vivo animal testing. There is general consensus, however, about the need for the development of alternative methodologies to allow researchers to more rapidly and cost effectively screen large numbers of chemicals for their potential to cause NT, or to investigate their mode of action. In vitro assays are considered an important source of information for making regulatory decisions, and human cell-based systems are recommended as one of the most relevant models in toxicity testing, to reduce uncertainty in the extrapolation of results from animal-based models. Human neuronal models range from various neuroblastoma cell lines to stem cell-derived systems, including those derived from mesenchymal stem/stromal cells (hMSC). hMSCs exhibit numerous advantages, including the fact that they can be obtained in high yield from healthy human adult tissues, can be cultured with a minimal laboratory setup and without genetic manipulations, are able of continuous and repeated self-renewal, are nontumorigenic, and can form large populations of stably differentiated cells representative of different tissues, including neuronal cells. hMSCs derived from human umbilical cord (hUC) in particular possess several prominent advantages, including a painless, non-invasive, and ethically acceptable collection procedure, simple and convenient preparation, and high proliferation capacity. In addition, hMSCs can be efficiently differentiated into neuron-like cells (hNLCs), which can then be used for the assessment of neuronal toxicity of potential neurotoxic compounds in humans. Here, we describe a step-by-step procedure to use hMSCs from the umbilical cord for in vitro neurotoxicity testing. First, we describe how to isolate, amplify, and store hMSCs derived from the umbilical cord. We then outline the steps to transdifferentiate these cells into hNLCs, and then use the hNLCs for neurotoxicity testing by employing multiple common cytotoxicity assays after treatment with test compounds. The approach follows the most updated guidance on using human cell-based systems. These protocols will allow investigators to implement an alternative system for obtaining primary NLCs of human origin, and support advancement in neurotoxicity research. © 2022 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Isolation and maintenance of human mesenchymal stem/stromal cells (hMSCs) obtained from the umbilical cord lining membrane Basic Protocol 2: Transdifferentiation of hMSCs into neuron-like cells (hNLCs) and basic neurotoxicity assessment.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e423Informations de copyright
© 2022 The Authors. Current Protocols published by Wiley Periodicals LLC.
Références
Amari, A., Ebtekar, M., Moazzeni, S. M., Soleimani, M., Amirabad, L. M., Tahoori, M. T., & Massumi, M. (2015). Investigation of immunomodulatory properties of human Wharton's Jelly-derived mesenchymal stem cells after lentiviral transduction. Cellular Immunology, 293(2), 59-66. doi: 10.1016/j.cellimm.2014.12.003.
Ankrum, J. A., Ong, J. F., & Karp, J. M. (2014). Mesenchymal stem cells: Immune evasive, not immune privileged. Nature Biotechnology, 32(3), 252-260. doi: 10.1038/nbt.2816.
Aras, M. A., Hartnett, K. A., & Aizenman, E. (2008). Assessment of cell viability in primary neuronal cultures. Current Protocols in Neuroscience, 44, 7.18.1-7.18.10. doi: 10.1002/0471142301.ns0718s44.
Arutyunyan, I., Elchanino, A., Makaro, A., & Fatkhudino, T. (2016). Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells International, 2016, 1-17. doi: 10.1155/2016/6901286.
Bal-Price, A., & Coecke, S. (2011). Guidance on Good Cell Culture Practice (GCCP). In M. Aschner, C. Suñol, & A. Bal-Price (Eds). Cell culture technique: Neuromethods (Vol. 56, pp, 1-25). New York: Springer.
Bal-Price, A., Crofton, K. M., Leist, M., Allen, S., Arand, M., Buetler, T., … Fritsche, E. (2015). International STakeholder NETwork (ISTNET): Creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes. Archives of Toxicology, 89(2), 269-287. doi: 10.1007/s00204-015-1464-2.
Bal-Price, A. K., & Pistollato, F. (2019). Application of non-animal methods to more effective neurotoxicity testing for regulatory purposes. In M. Aschner & L. Costa (Eds.), Cell culture techniques, neuromethods (Vol. 145). New York: Springer. doi: 10.1007/978-1-4939-9228-7_15.
Beeravolu, N., McKee, C., Alamri, A., Mikhael, S., Brown, C., Perez-Cruet, M., & Chaudhry, G. R. (2017). Isolation and characterization of mesenchymal stromal cells from human umbilical cord and fetal placenta. Journal of Visualized Experiments, 122, e55224, 1-13. doi: 10.3791/55224.
Bosch, J., Houben, A. P., Radke, T. F., Stapelkamp, D., Bünemann, E., Balan, P., … Kögler, G. (2012). Distinct differentiation potential of “MSC” derived from cord blood and umbilical cord: Are cord-derived cells true mesenchymal stromal cells? Stem Cells and Development, 21, 1977-1988. doi: 10.1089/scd.2011.0414.
Breier, J. M., Gassmann, K., Kayser, R., Stegeman, H., De Groot, D., Fritsche, E., & Shafer, T. J. (2009). Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: State of the science. Neurotoxicology and Teratology, 32(1), 4-15. doi: 10.1016/j.ntt.2009.06.005.
Buzanska, L., Sypecka, J., Nerini-Molteni, S., Compagnoni, A., Hogberg, H. T., del Torchio, R., … Coecke, S. (2009). A human stem cell-based model for identifying adverse effects of organic and inorganic chemicals on the developing nervous system. Stem Cells, 27, 2591-2601. doi: 10.1002/stem.179.
Chen, S., Zhang, W., Wang, J. M., Duan, H. T., Kong, J. H., Wang, Y. X., … Song, J. (2016). Differentiation of isolated human umbilical cord mesenchymal stem cells into neural stem cells. International Journal of Ophthalmology, 9(1), 41-47. doi: 10.18240/ijo.2016.01.07.
Coccini, T., Caloni, F., Cando, R. L. J., & De Simone, U. (2017). Cytotoxicity and proliferative capacity impairment induced on human brain cell cultures after short- and long-term exposure to magnetite nanoparticles. Journal of Applied Toxicology, 37(3), 361-373. doi: 10.1002/jat.3367.
Coccini, T., De Simone, U., Roccio, M., Croce, S., Lenta, E., Zecca, M., … Avanzini, M. A. (2019). In vitro toxicity screening of magnetite nanoparticles by applying mesenchymal stem cells derived from human umbilical cord lining. Journal of Applied Toxicology, 39, 1320-1336. doi: 10.1002/jat.3819.
Coccini, T., Pignatti, P., Spinillo, A., & De Simone, U. (2020). Developmental neurotoxicity screening for nanoparticles using neuron-like cells of human umbilical cord mesenchymal stem cells: Example with magnetite nanoparticles. Nanomaterials, 10, 1-28. doi: 10.3390/nano10081607.
Coccini, T., De Simone, U., Lonati, D., Scaravaggi, G., Marti, M., & Locatelli, C. A. (2021). MAM-2201, one of the most potent-naphthoyl Indole derivative-synthetic cannabinoids, exerts toxic effects on human cell-based models of neurons and astrocytes. Neurotoxicity Research, 39(4), 1251-1273. doi: 10.1007/s12640-021-00369-3.
Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., … Stokes, W. (2005). Guidance on good cell culture practice. A Report of the Second ECVAM Task force on good cell culture practice. Alternatives to Laboratory Animals, 33, 261-287. doi: 10.1177/026119290503300313.
Coecke, S., Goldberg, A. M., Allen, S., Buzanska, L., Calamandrei, G., Crofton, K., … Bal-Price, A. (2007). Workgroup report: Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environmental Health Perspectives, 115(6), 924-931. doi: 10.1289/ehp.9427.
Cortés-Medina, L. V., Pasantes-Morales, H., Aguilera-Castrejon, A., Picones, A., Lara-Figueroa, C. O., Luis, E., … Ramos-Mandujano, G. (2019). Neuronal transdifferentiation potential of human mesenchymal stem cells from neonatal and adult sources by a small molecule cocktail. Stem Cells International, 2019, 7627148. doi: 10.1155/2019/7627148.
Costa, L. G., Pellacani, C., & Guizzetti, M. (2017). In vitro and alternative approaches to developmental neurotoxicity. In R. C. Gupta (Ed.), Reproductive and developmental toxicology (2nd ed., pp. 241-253). San Diego: Academic Press. doi: 10.1016/B978-0-12-804239-7.00014-7.
Costain, W. J., Tauskela, J. S., Rasquinha, I., Comas, T., Hewitt, M., Marleau, V., & Soo, E. C. (2016). Pharmacological characterization of emerging synthetic cannabinoids in HEK293T cells and hippocampal neurons. European Journal of Pharmacology, 786, 234-245. doi: 10.1016/j.ejphar.2016.05.040.
Czarnecka, J., Porowińska, D., Bajek, A., Hołysz, M., & Roszek, K. (2017). Neurogenic differentiation of mesenchymal stem cells induces alterations in extracellular nucleotides metabolism. Journal of Cellular Biochemistry, 118(3), 478-486. doi: 10.1002/jcb.25664.
Daneshian, M., Busquet, F., Hartung, T., & Leist, M. (2015). Animal use for science in Europe. ALTEX, 32(4), 261-274. doi: 10.14573/altex.1509081.
De Bruyn, C., Najar, M., Raicevic, G., Meuleman, N., Pieters, K., Stamatopoulos, B., … Lagneaux, L. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells and Development, 20(3), 547-557. doi: 10.1089/scd.2010.0260.
De Simone, U., Spinillo, A., Caloni, F., Gribaldo, L., & Coccini, T. (2020). Neuron-like cells generated from human umbilical cord lining-derived mesenchymal stem cells as a new in vitro model for neuronal toxicity screening: Using magnetite nanoparticles as an example. International Journal of Molecular Sciences, 21(1), 271. doi: 10.3390/ijms21010271.
Díez, J. M., Bauman, E., Gajardo, R., & Jorquera, J. I. (2015). Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools. Stem Cell Research & Therapy, 6(1), 28. doi: 10.1186/s13287-015-0016-2.
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., … Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315-317. doi: 10.1080/14653240600855905.
Ducray, A. D., Stojiljkovic, A., Möller, A., Stoffel, M. H., Widmer, H. R., Frenz, M., & Mevissen, M. (2017). Uptake of silica nanoparticles in the brain and effects on neuronal differentiation using different in vitro models. Nanomedicine, 13, 1195-1204. doi: 10.1016/j.nano.2016.11.001.
European Commission. (2013). Seventh Report on the Statistics on the Number of Animals used for Experimental and other Scientific Purposes in the Member States of the European Union. Available at http://ec.europa.eu/environment/chemicals/labanimals/reportsen.htm.
Friedenstein, A. J., Piatetzky-Shapiro, I. I., & Petrakova, K. V. (1966). Osteogenesis in transplants of bone marrow cells. Journal of Embryology and Experimental Morphology, 16(3), 381-390.
Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., & Frolova, G. P. (1968). Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 6, 230-247. doi: 10.1097/00007890-196803000-00009.
George, S., Hamblin, M. R., & Abrahamse, H. (2019). Differentiation of mesenchymal stem cells to neuroglia: In the context of cell signalling. Stem Cell Reviews and Reports, 15(6), 814-826. doi: 10.1007/s12015-019-09917-z.
Gliga, A. R., Edoff, K., Caputo, F., Källman, T., Blom, H., Karlsson, H. L., … Fadeel, B. (2017). Cerium oxide nanoparticles inhibit differentiation of neural stem cells. Scientific Reports, 71, 9284. doi: 10.1038/s41598-017-09430-8.
Goulart, V. A., Braga Ferreira, L., Angélico Duarte, C., Lemos de Lima, I., Ferreira, E. R., Candido de Oliveira, B., … de Souza Castro-Filice, L. (2018). Mesenchymal stem cells from human adipose tissue and bone repair: A literature review. Biotechnology Research and Innovation, 2(1), 74-80, doi: 10.1016/j.biori.2017.10.005.
Harry, G. J., Billingsley, M., Bruinink, A., Campbell, I. L., Classen, W., Dorman, D. C., … Tilson, H. A. (1998). In vitro techniques for the assessment of neurotoxicity. Environmental Health Perspectives, 106(Suppl 1), 131-158. doi: 10.1289/ehp.98106s1131.
Harry, G. J., & Tiffany-Castiglioni, E. (2005). Evaluation of neurotoxic potential by use of in vitro systems. Expert Opinion on Drug Metabolism & Toxicology, 1(4), 701-713. doi: 10.1517/17425255.1.4.701.
Hartung, T. (2010). Lessons learned from alternative methods and their validation for a new toxicology in the 21st century. Journal of Toxicology and Environmental Health, Part B, Critical Reviews, 13(2-4), 277-290. doi: 10.1080/10937404.2010.483945.
Heo, J. S., Choi, Y., Kim, H. S., & Kim, H. O. (2016). Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. International Journal of Molecular Medicine, 37(1), 115-125. doi: 10.3892/ijmm.2015.2413.
Hernández, R., Jiménez-Luna, C., Perales-Adán, J., Perazzoli, G., Melguizo, C., & Prados, J. (2020). Differentiation of human mesenchymal stem cells towards neuronal lineage: Clinical trials in nervous system disorders. Biomolecules & Therapeutics, 28(1), 34-44. doi: 10.4062/biomolther.2019.065.
Irie, T., Kikura-Hanajiri, R., Usami, M., Uchiyama, N., Goda, Y., & Sekino, Y. (2015). MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors. Neuropharmacology, 95, 479-491. doi: 10.1016/j.neuropharm.2015.02.025.
Jang, S., Cho, H. H., Cho, Y. B., Park, J. S., & Jeong, H. S. (2010). Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biology, 11, 25. doi: 10.1186/1471-2121-11-25.
Jeschke, M. G., Gauglitz, G. G., Phan, T. T., Herndon, D. N., & Kita, K. (2011). Umbilical cord lining membrane and wharton's jelly-derived mesenchymal stem cells: The similarities and differences. The Open Tissue Engineering and Regenerative Medicine Journal, 4, 21-27. doi: 10.2174/1875043501104010021.
Jin, J. H., Bae, K. Y., Kim, M., Kwon, S. J., Jeon, H. B., Choi, S. J., … Chang, J. W. (2013). Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. International Journal of Molecular Sciences, 14, 17986-18001. doi: 10.3390/ijms140917986.
Karahuseyinoglu, S., Cinar, O., Kilic, E., Kara, F., Akay, G. G., Demiralp, D. O., … Can, A. (2007). Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells, 25, 319-331. doi: 10.1634/stemcells.2006-0286.
Kashyap, M. P., Kumar, V., Singh, A. K., Tripathi, V. K., Jahan, S., Pandey, A., … Pant, A. B. (2015). Differentiating neurons derived from human umbilical cord blood stem cells work as a test system for developmental neurotoxicity. Molecular Neurobiology, 51, 791-807. doi: 10.1007/s12035-014-8716-7.
Kikuchi-Taura, A., Taguchi, A., Kanda, T., Inoue, T., Kasahara, Y., Hirose, H., … Soma, T. (2012). Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells. Cytotherapy, 14, 441-450. doi: 10.3109/14653249.2012.658911.
Kil, K., Choi, M. Y., & Park, K. H. (2016). In vitro differentiation of human Wharton's jelly-derived mesenchymal stem cells into auditory hair cells and neurons. Journal of International Advanced Otology, 12, 37-42. doi: 10.5152/iao.2016.1190.
Kim, T. W., Che, J. H., & Yun, J. W. (2019). Use of stem cells as alternative methods to animal experimentation in predictive toxicology. Regulatory Toxicology and Pharmacology, 105, 15-29. doi: 10.1016/j.yrtph.2019.03.016.
Kita, K., Gauglitz, G. G., Phan, T. T., Herndon, D. N., & Jeschke, M. G. (2010). Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells and Development, 19(4), 491-502. doi: 10.1089/scd.2009.0192.
Koaykul, C., Kim, M. H., Kawahara, Y., Yuge, L., & Kino-Oka, M. (2019). Maintenance of neurogenic differentiation potential in passaged bone marrow-derived human mesenchymal stem cells under simulated microgravity conditions. Stem Cells and Development, 28(23), 1552-1561. doi: 10.1089/scd.2019.0146.
Krewski, D., Andersen, M. E., Tyshenko, M. G., Krishnan, K., Hartung, T., Boekelheide, K., … Cote, I. (2020). Toxicity testing in the 21st century: Progress in the past decade and future perspectives. Archives of Toxicology, 94(1), 1-58. doi: 10.1007/s00204-019-02613-4.
La Rocca, G., Anzalone, R., Corrao, S., Magno, F., Loria, T., Lo Iacono, M., … Farina, F. (2009). Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: Differentiation potential and detection of new markers. Histochemistry and Cell Biology, 131(2), 267-282. doi: 10.1007/s00418-008-0519-3.
Lee, S. J., & Lee, H. A. (2020). Trends in the development of human stem cell-based non-animal drug testing models. The Korean Journal of Physiology & Pharmacology, 24(6), 441-452. doi: 10.4196/kjpp.2020.24.6.441.
Leist, M., Hasiwa, N., Rovida, C., Daneshian, M., Basketter, D., Kimber, I., … Hartung, T. (2014). Consensus report on the future of animal-free systemic toxicity testing. ALTEX, 31(3), 341-356. doi: 10.14573/altex.1406091.
Lim, I. J., & Phan, T. T. (2014). Epithelial and mesenchymal stem cells from the umbilical cord lining membrane. Cell Transplantation, 23, 497-503. doi: 10.3727/096368914x678346.
Majore, I., Moretti, P., Stahl, F., Hass, R., & Kasper, C. (2011). Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Reviews and Reports, 7, 17-31. doi: 10.1007/s12015-010-9165-y.
Makris, S. L., Raffaele, K., Allen, S., Bowers, W. J., Hass, U., Alleva, E., … Crofton, K. M. (2009). A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environmental Health Perspectives, 117, 17-25. doi: 10.1289/ehp.11447.
Masjosthusmann, S., Barenys, M., El-Gamal, M., Geerts, L., Gerosa, L., Gorreja, A., … Fritsche, E. (2018). Literature review and appraisal on alternative neurotoxicity testing methods. EFSA, External Scientific Report, 15(4), 1-125. doi: 10.2903/sp.efsa.2018.EN-1410.
Mennan, C., Wright, K., Bhattacharjee, A., Balain, B., Richardson, J., & Roberts, S. (2013). Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord. BioMed Research International, 2013, 916136. doi: 10.1155/2013/916136.
Mennan, C., Brown, S., McCarthy, H., Mavrogonatou, E., Kletsas, D., Garcia, J., … Roberts, S. (2016). Mesenchymal stromal cells derived from whole human umbilical cord exhibit similar properties to those derived from Wharton's jelly and bone marrow. FEBS Open Bio, 6(11), 1054-1066. doi: 10.1002/2211-5463.12104.
Mitchell, K. E., Weiss, M. L., Mitchell, B. M., Martin, P., Davis, D., Morales, L., … Medicetty, S. (2003). Matrix cells from Wharton's jelly form neurons and glia. Stem Cells, 21, 50-60. doi: 10.1634/stemcells.21-1-50.
Nagamura-Inoue, T., & He, T. (2014). Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World Journal of Stem Cells, 6(2), 195-202. doi: 10.4252/wjsc.v6.i2.195.
Nan, C., Guo, L., Zhao, Z., Ma, S., Liu, J., Yan, D., … Liu, H. (2016). Tetramethylpyrazine induces differentiation of human umbilical cord-derived mesenchymal stem cells into neuron-like cells in vitro. International Journal of Oncology, 48(6), 2287-2294. doi: 10.3892/ijo.2016.3449.
OECD. (1997). Test Guideline 424. Neurotoxicity Study in Rodents.
OECD. (2007). Test guideline 426. OECD guideline for testing of chemicals. Developmental Neurotoxicity Study.
OECD. (2011). Test Guideline 443. Extended One-Generation Reproductive Toxicity Study.
Padiolleau, L., Chanseau, C., Durrieu, S., Ayela, C., Laroche, G., & Durrieu, M. C. (2020). Directing hMSCs fate through geometrical cues and mimetics peptides. Journal of Biomedical Materials Research Part A, 108(2), 201-211. doi: 10.1002/jbm.a.36804.
Patel, M., & Yang, S. (2010). Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Reviews, 6, 367-380. doi: 10.1007/s12015-010-9123-8.
Patil, V. R., Kharat, A. H., Kulkarni, D. G., Kheur, S. M., & Bhonde, R. R. (2018). Long term explant culture for harvesting homogeneous population of human dental pulp stem cells. Cell Biology International, 42(12), 1602-1610. doi: 10.1002/cbin.11065.
Pereira, W. C., Khushnooma, I., Madkaikar, M., & Ghosh, K. (2008). Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation. Journal of Tissue Engineering and Regenerative Medicine, 2, 394-399. doi: 10.1002/term.107.
Prieto, P., Clemedson, C., Meneguz, A., Pfaller, W., Sauer, U. G., & Westmoreland, C. (2005). Subacute and subchronic toxicity. Alternatives to Laboratory Animals, 33(Suppl 1), 109-116. doi: 10.1177/026119290503301s12.
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., … Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147. doi: 10.1126/science.284.5411.143.
Radio, N. M., & Mundy, W. R. (2008). Developmental neurotoxicity testing in vitro: Models for assessing chemical effects on neurite outgrowth. Neurotoxicology, 29(3), 361-376. doi: 10.1016/j.neuro.2008.02.011.
Raileanu, V. N., Whiteley, J., Chow, T., Kollara, A., Mohamed, A., Keating, A., & Rogers, I. M. (2019). Banking mesenchymal stromal cells from umbilical cord tissue: Large sample size analysis reveals consistency between donors. Stem Cells Translational Medicine, 8(10), 1041-1054. doi: 10.1002/sctm.19-0022.
Ramos, T. V., Mathew, A. J., Thompson, M. L., & Ehrhardt, R. O. (2014). Standardized cryopreservation of human primary cells. Current Protocols in Cell Biology, 64, A.3I., 1-8. doi: 10.1002/0471143030.cba03is64.
Rostami, A. A., Kouchesfahani, H. M., Kiani, S., & Fakheri, R. (2015). Iron oxide nanoparticles reduced retinoic acid induced-neuronal differentiation of mouse embryonic stem cells by ROS generation. Archives of Iranian Medicine, 18(9), 586-590.
Saleh, R., & Reza, H. M. (2017). Short review on human umbilical cord lining epithelial cells and their potential clinical applications. Stem Cell Research & Therapy, 8(1), 222. doi: 10.1186/s13287-017-0679-y.
Salehinejad, P., Alitheen, N. B., Ali, A. M., Omar, A. R., Moshrefi, M., Motamedi, B., & Nematollahi-Mahani, S. N. (2015). Neural differentiation of human umbilical cord matrix-derived mesenchymal cells under special culture conditions. Cytotechnology, 67(3), 449-460. doi: 10.1007/s10616-014-9703-6.
Seonwoo, H., Jang, K. J., Lee, D., Park, S., Lee, M., Park, S., … Chung, J. H. (2018). Neurogenic differentiation of human dental pulp stem cells on graphene-polycaprolactone hybrid nanofibers. Nanomaterials, 8(7), 554. doi: 10.3390/nano8070554.
Shahbazi, A., Safa, M., Alikarami, F., Kargozar, S., Asadi, M. H., Joghataei, M. T., & Soleimani, M. (2016). Rapid induction of neural differentiation in human umbilical cord matrix mesenchymal stem cells by camp-elevating agents. International Journal of Molecular and Cellular Medicine, 5(3), 167-177.
Shi, Y., Nan, C., Yan, Z., Liu, L., Zhou, J., Zhao, Z., & Li, D. (2018). Synaptic plasticity of human umbilical cord mesenchymal stem cell differentiating into neuron-like cells in vitro induced by edaravone. Stem Cells International, 2018, 5304279. doi: 10.1155/2018/5304279.
Singh, S., Srivastava, A., Kumar, V., Pandey, A., Kumar, D., Rajpurohit, C. S., … Pant, A. B. (2016). Stem cells in neurotoxicology/developmental neurotoxicology: Current scenario and future prospects. Molecular Neurobiology, 53, 6938-6949. doi: 10.1007/s12035-015-9615-2.
Singh, A. K., & Kashyap, M. P. (2016). An overview on human umbilical cord blood stem cell-based alternative in vitro models for developmental neurotoxicity assessment. Molecular Neurobiology, 53, 3216-3226. doi: 10.1007/s12035-015-9202-6.
Soenen, S. J. H., Nuytten, N., De Meyer, S. F., De Smedt, S. C., & De Cuyper, M. (2010). High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signalling. Small, 6(7), 832-842. doi: 10.1002/smll.200902084.
Strober, W. (2015). Trypan blue exclusion test of cell viability. Current Protocols in Immunology, 111, A.3B.1-A.3B.4.21. doi: 10.1002/0471142735.ima03bs21.
Stubbendorff, M., Deuse, T., Hua, X., Phan, T. T., Bieback, K., Atkinson, K., … Schrepfer, S. (2013). Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue. Stem Cells and Development, 22(19), 2619-2629. doi: 10.1089/scd.2013.0043.
Suma, R. N., & Mohanan, P. V. (2015). Stem cells, a new generation model for predictive nanotoxicological assessment. Current Drug Metabolism, 16, 932-939. doi: 10.2174/1389200216666151015113720.
Takahashi, D., Mori, T., Sohara, E., Tanaka, M., Chiga, M., Inoue, Y., … Uchida, S. (2017). WNK4 is an adipogenic factor and its deletion reduces diet-induced obesity in mice. EBioMedicine, 18, 118-127. doi: 10.1016/j.ebiom.2017.03.011.
Taran, R., Mamidi, M. K., Singh, G., Dutta, S., Parhar, I. S., John, J. P., … Das, A. K. (2014). In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources. Journal of Biosciences, 39(1), 157e69. doi: 10.1007/s12038-013-9409-5.
Tauskela, J. S., Comas, T., Hewitt, M., Aylsworth, A., Zhao, X., Martina, M., & Costain, W. J. (2016). Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca2+ spiking and multi-electrode arrays. European Journal of Pharmacology, 786, 148-160. doi: 10.1016/j.ejphar.2016.05.038.
Tomiyama, K., & Funada, M. (2011). Cytotoxicity of synthetic cannabinoids found in “Spice” products: The role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line. Toxicology Letters, 207, 12-17. doi: 10.1016/j.toxlet.2011.08.021.
Tomiyama, K., & Funada, M. (2014). Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: The involvement of cannabinoid CB1 receptors and apoptotic cell death. Toxicology and Applied Pharmacology, 274, 17-23. doi: 10.1016/j.taap.2013.10.028.
US-EPA. (1998). Health Effects Test Guidelines OPPTS 870.6300 Developmental Neurotoxicity Study. (EPA 712-C-98-239).
Viswanathan, S., Shi, Y., Galipeau, J., Krampera, M., Leblanc, K., Martin, I., … Sensebe, L. (2019). Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy, 21, 1019-1024. doi: 10.1016/j.jcyt.2019.08.002.
Wang, H. S., Hung, S. C., Peng, S. T., Huang, C. C., Wei, H. M., Guo, Y. J., … Chen, C. C. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 22, 1330-1337. doi: 10.1634/stemcells.2004-0013.
Wobus, A. M., & Löser, P. (2011). Present state and future perspectives of using pluripotent stem cells in toxicology research. Archives of Toxicology, 85(2), 79-117. doi: 10.1007/s00204-010-0641-6.
Worth, A. P., & Balls, M. (2002). Alternative (non-animal) methods for chemical testing: Current status and future prospects. ATLA, 30(Suppl 1), 1-125.
Yang, H., Xie, Z. H., Wei, L. F., Yang, H. N., Yang, S. N., Zhu, Z. Y., … Bi, J. Z. (2013). Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model. Stem Cell Research & Therapy, 4(4), 76. doi: 10.1186/scrt227.
Zakrzewski, W., Dobrzyński, M., Szymonowicz, M., & Rybak, Z. (2019). Stem cells: Past, present, and future. Stem Cell Research & Therapy, 10(1), 68. doi: 10.1186/s13287-019-1165-5.
Zomer, H. D., Vidane, A. S., Gonçalves, N. N., & Ambrósio, C. E. (2015). Mesenchymal and induced pluripotent stem cells: General insights and clinical perspectives. Stem Cells Cloning, 8, 125-134. doi: 10.2147/SCCAA.S88036.
Zychowicz, M., Dziedzicka, D., Mehn, D., Kozlowska, H., Kinsner-Ovaskainen, A., Stepien, P. P., … Buzanska, L. (2014). Developmental stage dependent neural stem cells sensitivity to methylmercury chloride on different biofunctional surfaces. Toxicology in Vitro, 28, 76-87. doi: 10.1016/j.tiv.2013.06.023.